SCI
13April
AttributableFailureofFirst-lineCancerTreatmentandIncrementalCostsAssociatedWithSmokingbyPatientsWithCancerWarrenGW,CartmellKB,Garrett-MayerE,SalloumRG,CummingsKM.AttributableFailureofFirst-lineCancerTreatmentandIncrementalCostsAssociatedWithSmokingbyPatientsWithCancer.JAMANetwOpen;2:e
CorrespondingAuthor:
GrahamW.Warren,MD,PhD,DepartmentofRadiationOncology,MedicalUniversityofSouthCarolina,AshleyAve,MSC,Charleston,SC(warrengw
musc.edu).IMPORTANCE重要性
Previousstudieshaveshownthatcontinuedsmokingamongpatientswithcancercanincreaseoverallandcancer-specificmortality,riskforsecondprimarycancer,andriskfortoxiceffectsofcancertreatment.Toourknowledge,therehavebeennoeffortstoestimateadditionalcostsforcancertreatmentattributedtosmoking.
先前研究表明，癌症患者继续吸烟会增加总体和癌症特异性死亡率、第二原发癌风险以及癌症治疗的毒性作用风险。据了解，尚未有关研究评估因吸烟而增加的癌症治疗费用。
OBJECTIVE目标
Tomodelattributableincrementalcostsofsubsequentcancertreatmentassociatedwithcontinuedsmokingbypatientswithcancer.
对癌症患者持续吸烟导致的癌症后续治疗成本的增加量建立模型。
设计、设置和参与者
Forthiseconomicevaluation,amodelwasdevelopedinusingdatafromaUSSurgeonGeneral’sreportthatconsideredexpectedfailureratesoffirst-linecancertreatmentinnonsmokingpatients,smokingprevalence,oddsratiooffirst-linecancertreatmentfailureattributedtosmoking